Journal of Genetic Engineering and Biotechnology

Table 3 Comparison between genotype SOD in ESRD among clinical data

From: Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients

		Genotype SOD						One way ANOVA
		Ala/Ala		Val/Ala		Val/Val		One way ANOVA
								F	P
Hb Conc.		10.21	1.61	10.36	1.82	9.93	2.05	0.524	0.594
Duration of dialysis (months)		10.40	8.25	20.00	25.96	40.74	42.06	5.398	0.006
Ca Conc.		7.65	1.78	8.07	1.12	8.49	0.97	3.150	0.047
Phosphate		4.85	1.43	6.20	2.39	6.04	2.51	1.277	0.283
PTH		449.20	318.01	439.66	380.49	503.33	489.40	0.236	0.791
Creat Conc.		8.07	3.39	8.00	3.52	8.12	2.71	0.016	0.984
Bilirubin		0.67	0.15	0.61	0.22	0.63	0.19	0.397	0.673
Albumin		3.99	0.33	3.85	0.46	3.80	0.43	0.846	0.432
SGPT		19.90	6.51	29.94	22.03	26.71	23.34	0.819	0.444
SGOT		21.70	4.03	33.38	21.26	30.26	22.65	1.164	0.317
FBS		156.70	80.88	106.03	39.87	131.00	75.82	2.672	0.074
		No	%	No	%	No	%	Chi-square test
HBsAg	Negative	10	100.00	2	100.00	30	100.00	NA	NA
HCV	Negative	10	100.00	2	100.00	20	66.70	5.131	0.162
HCV	Positive	0	0.00	0	0.00	10	33.30	5.131	0.162

Back to article page